The results showed that when compared with chemo alone, CKI combined with chemo dramatically improved immune function in patients with NSCLC (MD = 0.82, 95% CI: 0.12 to 1.52; P=0.02) (Figure 4). The gene discussed is CHKA; the disease is non-small cell lung carcinoma.